Variation of platelet function in clinical phenotypes of acute venous thromboembolism – Results from the GMP‐VTE project

Background The role of platelets in the pathogenesis of venous thromboembolism (VTE) is receiving increasing attention; however, limited information is available on platelet function in the acute phase of the disease. Objective To characterize platelet function according to VTE phenotypes. Patients/...

Full description

Saved in:
Bibliographic Details
Published inJournal of thrombosis and haemostasis Vol. 20; no. 3; pp. 705 - 715
Main Authors Panova‐Noeva, Marina, Wagner, Bianca, Nagler, Markus, Koeck, Thomas, ten Cate, Vincent, Eggebrecht, Lisa, Prochaska, Jürgen H., Meyer, Imke, Gerdes, Christoph, Spronk, Henri M., Lackner, Karl J., ten Cate, Hugo, Leineweber, Kirsten, Heitmeier, Stefan, Konstantinides, Stavros, Wild, Philipp S.
Format Journal Article
LanguageEnglish
Published England Elsevier Limited 01.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The role of platelets in the pathogenesis of venous thromboembolism (VTE) is receiving increasing attention; however, limited information is available on platelet function in the acute phase of the disease. Objective To characterize platelet function according to VTE phenotypes. Patients/Methods In total, 154 subjects (isolated pulmonary embolism [iPE], n = 28; isolated deep vein thrombosis [iDVT], n = 35; DVT+PE, n = 91) were included. In this study platelet function analyzer (PFA)‐200, light transmission aggregometry (LTA), thrombin generation (TG) in presence (PRP) and absence (PFP) of platelets and platelet flow cytometry were investigated. LASSO regression was used to select clinical and platelet biomarkers that distinguish between VTE phenotypes. Results PFA‐200 results did not differ between VTE phenotypes. LTA from DVT+PE subjects showed lowest maximum aggregation after epinephrine and adenosine diphosphate compared to iPE and iDVT. Lower % of PAC‐1‐positive platelets after in‐vitro trigger were present in DVT+PE and iPE compared to iDVT. TG in PRP had lower peak height and velocity in DVT+PE and iPE against iDVT. The results of LASSO regression for the distinction between DVT+PE vs iDVT identified 18 variables (AUC =0.93) of which 72% were platelet biomarkers. For distinction between iPE and iDVT, 10 variables were selected (AUC = 0.96) of which 50% were platelet‐related. Obesity was the only variable weakly discriminating between DVT+PE vs iPE (AUC = 0.66). Conclusion This explorative study suggests an important distinction between PE‐related phenotypes and iDVT when considering clinical and platelet function data. Lower platelet‐dependent TG along with reduced platelet reactivity suggest higher platelet degranulation in PE‐dependent phenotypes compared to iDVT.
Bibliography:Funding information
The VTEval and FOCUS BioSeq studies, parent studies of the GMP‐VTE project, were supported by the German Federal Ministry of Education and Research (BMBF 01EO1003 and 01EO1503), internal funds of the Clinical Epidemiology and Systems Medicine (Center for Thrombosis and Hemostasis, Mainz, Germany), and a grant from Bayer AG.
Manuscript handled by: Matthew T. Rondina
Final decision: Matthew T. Rondina, 12 November 2021
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1538-7933
1538-7836
1538-7836
DOI:10.1111/jth.15595